These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27002801)

  • 1. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
    Hu C; Iyer RK; Juran BD; McCauley BM; Atkinson EJ; Eaton JE; Ali AH; Lazaridis KN
    BMC Gastroenterol; 2023 Apr; 23(1):129. PubMed ID: 37076803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
    Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
    Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
    Zenouzi R; Weismüller TJ; Jørgensen KK; Bubenheim M; Lenzen H; Hübener P; Schulze K; Weiler-Normann C; Sebode M; Ehlken H; Pannicke N; Hartl J; Peiseler M; Hübener S; Karlsen TH; Boberg KM; Manns MP; Lohse AW; Schramm C
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1806-1812. PubMed ID: 27521513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
    Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
    Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
    Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
    Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
    Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
    Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
    Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
    Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.